The Roles of Genetically Distinct Cortical Neuron Types in General-Anesthesia- and Sleep-Induced Slow Waves
遗传上不同的皮质神经元类型在全身麻醉和睡眠引起的慢波中的作用
基本信息
- 批准号:10449437
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-11 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic AgonistsAdrenergic ReceptorAffectAgonistAnesthesia proceduresAnestheticsAreaArousalAwarenessBilateralBiomimeticsBostonBrain StemCa(2+)-Calmodulin Dependent Protein KinaseCalciumCaliforniaCerebral cortexCommunity HospitalsConsciousDataDexmedetomidineEducational process of instructingElectroencephalogramExhibitsFacultyFrequenciesFutureGeneral AnesthesiaGeneral HospitalsGeneral anesthetic drugsGenerationsGoalsGrantHeadHealthImageIndividualInstitutesInterneuronsIntracellular MembranesKetamineLeadLearningLos AngelesMassachusettsMeasuresMedicalMembrane PotentialsMentorsMethodsMicroscopeMolecularMolecular TargetMonitorN-MethylaspartateNarcolepsyNeuronsOccupationsParvalbuminsPatternPeer ReviewPersonsPhasePrefrontal CortexPreoptic AreasPropofolProtocols documentationRattusResearchRodentRoleSleepSleep DisordersSleeplessnessSlow-Wave SleepSomatostatinStatistical Data InterpretationTechniquesTechnologyTestingTrainingUnconscious StateUniversitiesVasoactive Intestinal PeptideWritingantagonistbasecalcium indicatorcomputational neurosciencecortex mappingexperimental studyhippocampal pyramidal neuronimprovedinformation processinginhibitory neuronmedical schoolsmemberneural circuitneural stimulationnon rapid eye movementoptogeneticsparabrachial nucleuspatient safetypreventprogramsrelating to nervous systemside effect
项目摘要
Project Summary/Abstract. Reversible loss of consciousness is a crucial part of two major medical fields:
general anesthesia and sleep. General anesthetics and non-rapid-eye-movement (NREM) sleep both induce
slow waves (0.1-4 Hz) in the cortical electroencephalogram (EEG). It is unknown whether slow waves generated
with different anesthetic agents and during NREM sleep are generated with the same neural circuit activity. Dr.
Melonakos’ preliminary data suggests that anesthetic agents with different molecular targets have distinct slow
wave mechanisms (Aim 1 Hypothesis). In addition, although dexmedetomidine anesthesia shares neural circuits
with NREM sleep, it may also have distinct direct cortical effects, possibly leading to different slow wave activity
(Aim 2 Hypothesis). The purpose of this research is to test these hypotheses by mapping cortical neural activity
with respect to the EEG slow waves of both anesthesia and NREM sleep. In order to do this, Dr. Melonakos will
learn how to perform calcium imaging experiments in freely behaving rodents. He will then record calcium images
from Ca2+/calmodulin-dependent protein kinase IIa-positive (CaMKIIa+), parvalbumin-positive (PV+),
somatostatin-positive (SST+), and vasoactive intestinal peptide-positive (VIP+) cortical neurons during
anesthesia- and sleep-induced slow waves. Propofol, ketamine, and dexmedetomidine anesthesia will be tested.
Dr. Melonakos will then compare the neural activity between the anesthetics and between general anesthesia
and sleep. Finally, he will identify the role of SST+ neurons in slow waves (Aim 3 Hypothesis) by (1) looking at
the activity of cortical neurons following disruption of slow waves by stimulation of the parabrachial nucleus, an
arousal area in the brainstem, and (2) inhibiting SST+ neurons during anesthesia- and sleep-induced slow waves.
During the K99 phase of this project, Dr. Melonakos will be mentored by Drs. Christa Nehs and Emery Brown,
experts in anesthesia and sleep neurocircuitry and faculty at Harvard Medical School, Massachusetts General
Hospital (MGH), and Massachusetts Institute of Technology (MIT). Dr. Melonakos will also collaborate with Drs.
Michael Hasselmo (Boston University), Nancy Kopell (Boston University), and Daniel Aharoni (University of
California, Los Angeles). He will be trained in calcium imaging by Drs. Hasselmo and Aharoni, and statistical
analysis by Dr. Brown. Dr. Kopell will guide Dr. Melonakos as he orients his findings within hypothesized slow
wave mechanisms from the field of computational neuroscience. Dr. Melonakos will also learn optogenetics
stimulation techniques from Dr. Nehs and in a course at MIT. The mentors, collaborators, and other members of
the MGH community will also provide him with professional guidance as he nears independence, including
training in grant writing, peer review, teaching, and the faculty job search. The scientific and professional training
Dr. Melonakos receives will enable him to develop an independent research program to study anesthetics’ direct
vs. indirect effects. The resulting understanding of slow wave mechanisms has potential to improve the protocols
used to monitor general anesthesia and treat sleep disorders, thus benefiting patient safety and health.
项目摘要/摘要。可逆的意识丧失是两个主要医疗领域的关键部分:
全身麻醉和睡眠。全身麻醉和非依质 - 动作(NREM)睡眠两者都有影响
皮质脑电图(EEG)中的慢波(0.1-4 Hz)。尚不清楚慢波是否产生
具有不同的麻醉剂和在NREM睡眠期间,具有相同的神经回路活性。博士
Melonakos的初步数据表明,具有不同分子靶标的麻醉剂的慢速
波机制(AIM 1假设)。此外,尽管右美度胺麻醉有神经回路
使用NREM睡眠,它也可能具有不同的直接皮质作用,可能导致不同的慢波活动
(AIM 2假设)。这项研究的目的是通过绘制皮质神经元活性来检验这些假设
关于麻醉和NREM睡眠的脑电图慢波。为此,Melonakos博士将
了解如何在自由表现啮齿动物中执行钙成像实验。然后,他将记录钙图像
从Ca2+/钙调蛋白依赖性蛋白激酶IIA阳性(CAMKIIA+),白蛋白阳性(PV+),
生长抑素阳性(SST+)和血管活性肠道肽阳性(VIP+)皮质神经元期间
麻醉和睡眠引起的慢波。丙泊酚,氯胺酮和右美托咪定麻醉将进行测试。
然后,Melonakos博士将比较麻醉药之间的神经活动和全身麻醉之间
和睡觉。最后,他将通过(1)看SST+神经元在慢波(AIM 3假设)中的作用
通过刺激止痛核破坏慢波后皮质神经元的活性,
脑干中的唤醒区域,(2)在麻醉和睡眠引起的慢波中抑制SST+神经元。
在该项目的K99阶段,Melonakos博士将由Christa Nehs博士和Emery Brown博士考虑,
马萨诸塞州哈佛医学院的麻醉和睡眠神经记录和教师的专家
医院(MGH)和马萨诸塞州理工学院(MIT)。 Melonakos博士还将与Drs合作。
迈克尔·哈塞尔莫(Michael Hasselmo)(波士顿大学),南希·科佩尔(波士顿大学)和丹尼尔·阿哈罗尼(Daniel Aharoni)(大学
加利福尼亚,洛杉矶)。 DRS将对他进行钙成像的培训。 Hasselmo和Aharoni以及统计
布朗博士的分析。 Kopell博士将指导Melonakos博士在假设的慢速中提出他的发现
来自计算神经科学领域的波浪机制。 Melonakos博士还将学习光遗传学
NEHS博士和麻省理工学院的课程中的刺激技术。导师,合作者和其他成员
MGH社区还将在他近乎独立时为他提供专业指导,包括
赠款写作,同行评审,教学和教师求职培训。科学和专业培训
Melonakos博士收到的将使他能够制定一个独立的研究计划来研究麻醉药的直接
与间接影响。对慢波机制的理解有可能改善协议
用于监测全身麻醉和治疗睡眠障碍,从而使患者的安全和健康受益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric D Melonakos其他文献
Eric D Melonakos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric D Melonakos', 18)}}的其他基金
The Roles of Genetically Distinct Cortical Neuron Types in General-Anesthesia- and Sleep-Induced Slow Waves
遗传上不同的皮质神经元类型在全身麻醉和睡眠引起的慢波中的作用
- 批准号:
10601096 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
相似国自然基金
β2肾上腺素能受体基因多态性Arg16Gly影响慢性心衰预后及 β受体阻滞剂疗效的机制研究
- 批准号:81800356
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
抗β1/2肾上腺素能受体自身抗体表达增强对心房颤动的影响及机制研究
- 批准号:81660053
- 批准年份:2016
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
肾上腺素能受体SNPs及PWV、CBP对射血分数保留心衰的发病及药物敏感性的影响
- 批准号:81471402
- 批准年份:2014
- 资助金额:70.0 万元
- 项目类别:面上项目
肾上腺素联合艾司洛尔对复苏后心肌β-肾上腺素能受体信号通路及线粒体的影响
- 批准号:81372025
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
低切应力通过β1AR-mTOR信号转导通路影响内皮细胞eNOS功能的分子机制研究
- 批准号:81270191
- 批准年份:2012
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
- 批准号:
10680109 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
The role of VSNL1 in human heart rate regulation
VSNL1在人体心率调节中的作用
- 批准号:
10750747 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Understanding the role of β2AR-signaling on ILC2 differentiation/plasticity and its implications in cancer progression
了解 β2AR 信号传导对 ILC2 分化/可塑性的作用及其对癌症进展的影响
- 批准号:
10750348 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Development of small molecule Protease-activated-receptor-2 antagonists as oral asthma therapeutics
开发小分子蛋白酶激活受体 2 拮抗剂作为口服哮喘治疗药物
- 批准号:
10766584 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Development of microencapsulated PI301 targeting lung GABAergic signaling
开发针对肺 GABA 信号传导的微囊 PI301
- 批准号:
10478543 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别: